secwatch.observer — SEC 8-K summary
======================================

Issuer:     Health Catalyst, Inc. (HCAT)
CIK:        0001636422
Form:       8-K
Filed at:   2025-01-13T23:59:59+00:00
Accession:  0001636422-25-000010
Event type: m_and_a
Sentiment:  positive
Materiality: 0.80
Item codes: 1.01, 3.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Health Catalyst acquires Upfront Healthcare for ~$86M net; reports preliminary Q4 & FY2024 results and 2025 guidance
--------------------------------------------------------------------------------

- Upfront acquisition: ~$86M net consideration (cash + ~5.75M shares) plus up to ~$33.4M earn-out; expected Q1 2025 close.
- Preliminary Q4 2024 revenue $78.75-79.75M (+6% YoY), Adj. EBITDA $7.9M (10% margin).
- Full-year 2024 revenue $305.7-306.7M (+3%), Adj. EBITDA $26.1M (+137%, 9% margin).
- 2025 guidance: revenue ~$335M (+10%), Adj. EBITDA ~$39M (+49%, 12% margin).
- Net new platform clients 21 in 2024 (+91%); 2025 target ~40 (+90%).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636422/000163642225000010/0001636422-25-000010-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636422/000163642225000010/ajpmorganconferencejan2025.htm
  HTML page:      https://secwatch.observer/filing/0001636422-25-000010

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer